Liver biopsy interpretation for causes of late liver allograft dysfunction

Hepatology

Volumn 44, Issue 2, 2006, Pages 489-501

  Demetris, A J ^a   Demetris, Anthony J ^b   Adeyi, Oyedele ^c   Bellamy, Chris O C ^d   Clouston, Andrew ^e   Charlotte, Frederic ^f   Czaja, Albert ^g   Daskal, Ierachmiel ^h   El Monayeri, Magda S ⁱ   Fontes, Paulo ^b   Fung, John ^j   Gridelli, Bruno ^k   Guido, Maria ^l   Haga, Hironori ^m   Hart, John ⁿ   Honsova, Eva ^o   Hubscher, Stefan ^p   Itoh, Tomoo ^q   Jhala, Nirag ^r   Jungmann, Patricia ^s   Khettry, Urmila ^t   Lassman, Charles ^u   Ligato, Saverio ^v   Lunz, John G ^b   Marcos, Amadeo ^b   Minervini, Marta Ida ^k   Molne, Johan ^w   Nalesnik, Mike ^b   Nasser, Imad ^x   Neil, Desley ^p   Ochoa, Erin ^b   Pappo, Orit ^y   Randhawa, Parmjeet ^b   Reinholt, Finn P ^z   Ruiz, Phil ^aa   Sebagh, Mylene ^ab   Spada, Marco ^k   Sonzogni, Aurelio ^ac   Tsamandas, Athanassios C ^ad   Wernerson, Annika ^ae   Wu, Tong ^b   Yilmaz, Funda ^af   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g MAYO CLINIC   (United States)

^h Jefferson Health System Inc   (United States)

ⁱ AIN SHAMS UNIVERSITY   (Egypt)

^j LERNER RESEARCH INSTITUTE   (United States)

^k MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^l Istituto di Anatomia Umana Normale   (Italy)

^m KYOTO UNIVERSITY HOSPITAL   (Japan)

ⁿ UNIVERSITY OF CHICAGO   (United States)

^o INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^p UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^q HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^r UNIVERSITY OF ALABAMA HOSPITAL   (United States)

^s FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^t TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v HARTFORD HOSPITAL   (United States)

^w SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^x HARVARD MEDICAL SCHOOL   (United States)

^y HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^z OSLO UNIVERSITY HOSPITAL   (Norway)

^aa UNIVERSITY OF MIAMI   (United States)

^ab UNIVERSITÉ PARIS SACLAY   (France)

^ac OSPEDALI RIUNITI   (Italy)

^ad UNIVERSITY OF PATRAS   (Greece)

^ae KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^af EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; DISEASE COURSE; GENOTYPE; HEPATITIS C VIRUS; HISTOPATHOLOGY; INCIDENCE; LIVER BIOPSY; LIVER GRAFT; LIVER GRAFT REJECTION; NEEDLE BIOPSY; PATHOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECURRENT DISEASE; REVIEW; SCLEROSING CHOLANGITIS; SEROLOGY; SYMPTOMATOLOGY; VIRUS HEPATITIS;

EID: 33747080802     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21280     Document Type: Review

References (100)

1. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. HEPATOLOGY 2000;31:792-799.
2. Anonymous. Banff schema for grading liver allograft rejection: an international consensus document. HEPATOLOGY 1997;25:658-663.
3. Hunt J, Gordon FD, Jenkins RL, Lewis WD, Khettry U. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 1999;12:325-328.
4. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19:192-206.
5. Pappo O, Yunis E, Jordan JA, Jaffe R, Mateo R, Fung J, et al. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am J Surg Pathol 1994;18:804-813.
6. Starzl TE, Demetris AJ. Liver transplantation: a 31-year perspective. Part III. Curr Probl Surg 1990;27:187-240.
7. Ciubotariu R, Liu Z, Colovai AI, Ho E, Itescu S, Ravalli S, et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998;101:398-405.
8. Suciu-Foca N, Harris PE, Cortesini R. Intramolecular and intermolecular spreading during the course of organ allograft rejection. Immunol Rev 1998;164:241-246.
9. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002;2:85-95.
10. Rose NR. Mechanisms of autoimmunity. Semin Liver Dis 2002;22:387-394.
11. Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 1998;65:1072-1075.
12. Duclos-Vallee JC, Johanet C, Bach JF, Yamamoto AM. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. J Hepatol 2000;33:163-166.
13. Varani S, Muratori L, De Ruvo N, Vivarelli M, Lazzarotto T, Gabrielli L, et al. Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol 2002;66:56-62.
14. Lytton SD, Berg U, Nemeth A, Ingelman-Sundberg M. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Clin Exp Immunol 2002;127:293-302.
15. Benichou G. Spreading of T cell responses to autoantigens after allotransplantation and its potential involvement in the rejection process. Graft 2003;6:18-20.
16. Demetris AJ, Murase N, Delaney CP. Overlap between allo- and autoimmunity in the rat and human evidence for important contributions for dendritic and regulatory cells. Graft 2003;6:21-32.
17. Heeger PS. T cell autoreactivity by design:a theoretical framework for understanding tolerance, autoimmunity, and transplant rejection. Graft 2003;6:33-41.
18. Wilkes DS. Autoimmune responses to grafted lungs: immune responses to native collagen-type V collagen. Graft 2003;6:42-49.
19. Berenguer M, Rayon JM, Prieto M, Aguilera V, Nicolas D, Ortiz V, et al. Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 2001;7:790-796.
20. Burra P, Mioni D, Cecchetto A, Cillo U, Zanus G, Fagiuoli S, et al. Histological features after liver transplantation in alcoholic cirrhotics. J Hepatol 2001;34:716-722.
21. Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayon M, San Juan F, et al. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Liver Transpl 2003;9:1152-1158.
22. Sebagh M, Rifai K, Feray C, Yilmaz F, Falissard B, Roche B, et al. All liver recipients benefit from the protocol 10-year liver biopsies. HEPATOLOGY 2003;37:1293-1301.
23. Slapak GI, Saxena R, Portmann B, Gane E, Devlin J, Calne R, et al. Graft and systemic disease in long-term survivors of liver transplantation. HEPATOLOGY 1997;25:195-202.
24. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, et al. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg 1997;3:559-562.
25. Maor-Kendler Y, Batts KP, Burgart LJ, Wiesner RH, Krom RA, Rosen CB, et al. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation 2000;70:292-297.
26. Heneghan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, et al. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transpl 2003;9:921-928.
27. Wong T, Nouri-Aria KT, Devlin J, Portmann B, Williams R. Tolerance and latent cellular rejection in long-term liver transplant recipients. HEPATOLOGY 1998;28:443-449.
28. Gane E, Portmann B, Saxena R, Wong P, Ramage J, Williams R. Nodular regenerative hyperplasia of the liver graft after liver transplantation. HEPATOLOGY 1994;20:88-94.
29. Shinkura N, Ikai I, Egawa H, Yamauchi A, Kawai Y, Inomata Y, et al. Presence of anti-FKBP12 autoantibodies in patients with liver allografts: its association with allograft rejection. Transplantation 1997;64:1336-1342.
30. Salcedo M, Vaquero J, Banares R, Rodriguez-Mahou M, Alvarez E, Vicario JL, et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation. HEPATOLOGY 2002;35:349-356.
31. Gupta P, Hart J, Millis JM, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001;71:664-668.
32. Heneghan MA, Portmann BC, Norris SM, Williams R, Muiesan P, Rela M, et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. HEPATOLOGY 2001;34:464-470.
33. Hernandez HM, Kovarik P, Whitington PF, Alonso EM. Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001;32:131-136.
34. Aguilera I, Wichmann I, Sousa JM, Bernardos A, Franco E, Garcia-Lozano JR, et al. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol 2001;126:535-539.
35. Jones DE, James OF, Portmann B, Burt AD, Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. HEPATOLOGY 1999;30:53-57.
36. Kerkar N, Hadzic N, Davies ET, Portmann B, Donaldson PT, Rela M, et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 1998;351:409-413.
37. Salcedo M, Vaquero J, Banares R, Mahou MR, Alvarez E, Hernandez-Albujar A, et al. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders [Abstract]. J Hepatol 2003;34:47.
38. Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, Devera M, et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004;78:966-971.
39. Wright HL, Bou-Abboud CF, Hassanein T, Block GD, Demetris AJ, Starzl TE, et al. Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 1992;53:136-139.
40. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, et al. Liver transplantation for autoimmune hepatitis: a long-term pathologic study. HEPATOLOGY 2000;32:185-192.
41. Birnbaum AH, Benkov KJ, Pittman NS, McFarlane-Ferreira Y, Rosh JR, LeLeiko NS. Recurrence of autoimmune hepatitis in children after liver transplantation. J Pediatr Gastroenterol Nutr 1997;25:20-25.
42. Czaja AJ. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. Liver Transpl 2002;8:505-513.
43. Duclos-Vallee JC, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, et al. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 2003;52:893-897.
44. Faust TW. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Semin Liver Dis 2000;20:481-495.
45. Gonzalez-Koch A, Czaja AJ, Carpenter HA, Roberts SK, Charlton MR, Porayko MK, et al. Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl 2001;7:302-310.
46. Hurtova M, Duclos-Vallee JC, Johanet C, Emile JF, Roque-Afonso AM, Feray C, et al. Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient. Liver Transpl 2001;7:556-558.
47. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999;68:253-256.
48. Molmenti EP, Netto GJ, Murray NG, Smith DM, Molmenti H, Crippin JS, et al. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl 2002;8:519-526.
49. Reich DJ, Fiel I, Guarrera JV, Emre S, Guy SR, Schwartz ME, et al. Liver transplantation for autoimmune hepatitis. HEPATOLOGY 2000;32:693-700.
50. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, Krom RA, Wiesner RH. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. HEPATOLOGY 1992;15:215-221.
51. Devlin J, Donaldson P, Portmann B, Heaton N, Tan KC, Williams R. Recurrence of autoimmune hepatitis following liver transplantation. Liver Transpl Surg 1995;1:162-165.
52. Prados E, Cuervas-Mons V, de la Mata M, Fraga E, Rimola A, Prieto M, et al. Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998;66:1645-1650.
53. Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P, et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 1999;30:131-141.
54. Sempoux C, Horsmans Y, Lerut J, Rahier J, Geubel A. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver 1997;17:311-315.
55. Vogel A, Heinrich E, Bahr MJ, Rifai K, Flemming P, Melter M, et al. Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 2004;18:62-69.
56. Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Sakurai T, Minamiguchi S, et al. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation 2004;78:128-135.
57. Hubscher SG. Recurrent autoimmune hepatitis after liver transplantation: Diagnostic criteria, risk factors, and outcome. Liver Transpl 2001;7:285-291.
58. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy-a clinicopathologic study of 96 patients. Transplantation 1992;53:1056-1062.
59. Tsamandas AC, Jain AB, Felekouras ES, Fung JJ, Demetris AJ, Lee RG. Central venulitis in the allograft liver: a clinicopathologic study. Transplantation 1997;64:252-257.
60. Krasinskas AM, Ruchelli ED, Rand EB, Chittams JL, Furth EE. Central venulitis in pediatric liver allografts. HEPATOLOGY 2001;33:1141-1147.
61. Khettry U, Backer A, Ayata G, Lewis WD, Jenkins RL, Gordon FD. Centrilobular histopathologic changes in liver transplant biopsies. Hum Pathol 2002;33:270-276.
62. Lunz JG 3rd, Contrucci S, Ruppert K, Murase N, Fung JJ, Starzl TE, et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21 (WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol 2001;158:1379-1390.
63. Neil DA, Hubscher SG. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. HEPATOLOGY 2002;35:639-651.
64. Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, et al. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. HEPATOLOGY 2000;32:1240-1247.
65. Gordon FD, Pomfret EA, Pomposelli JJ, Lewis WD, Jenkins RL, Khettry U. Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. Hum Pathol 2004;35:636-638.
66. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. HEPATOLOGY 1992;16:865-876.
67. Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, Randhawa P, et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004;28:658-669.
68. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 1998;4:15-21.
69. Aguilera I, Sousa JM, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl 2004;10:1166-1172.
70. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.
71. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. HEPATOLOGY 2002;36:479-497.
72. Pratt DS, Fawaz KA, Rabson A, Dellelis R, Kaplan MM. A novel histological lesion in glucocorticoid-responsive chronic hepatitis. Gastroenterology 1997;113:664-668.
73. Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol 2003;19:232-242.
74. Singh R, Nair S, Farr G, Mason A, Perrillo R. Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 2002;97:2670-2673.
75. Okano N, Yamamoto K, Sakaguchi K, Miyake Y, Shimada N, Hakoda T, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res 2003;25:263-270.
76. Neuberger J. Chronic allograft dysfunction: diagnosis and management. Is it always progressive? Liver Transpl 2005;11:S63-S68.
77. Evans HM, Kelly DA, McKiernan PJ, Hübscher SG. Progressive histological damage in liver allografts following paediatric liver transplantation. HEPATOLOGY 2006;43:1109-1117.
78. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, et al. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991;23:3005-3006.
79. Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc 1989;21:2208-2210.
80. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18:173-184.
81. Neuberger J, Portmann B, Calne R, Williams R. Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. Transplantation 1984;37:363-365.
82. Sebagh M, Farges O, Dubel L, Samuel D, Bismuth H, Reynes M. Histological features predictive of recurrence of primary biliary cirrhosis after liver transplantation. Transplantation 1998;65:1328-1333.
83. Sebagh M, Yilmaz F, Karam V, Falissard B, Roche B, Azoulay D, et al. The histologic pattern of "biliary tract pathology" is accurate for the diagnosis of biliary complications. Am J Surg Pathol 2005;29:318-323.
84. White RM, Zajko AB, Demetris AJ, Bron KM, Dekker A, Starzl TE. Liver transplant rejection: angiographic findings in 35 patients. AJR Am J Roentgenol 1987;148:1095-1098.
85. Devlin J, Page AC, O'Grady J, Portmann B, Karani J, Williams R. Angiographically determined arteriopathy in liver graft dysfunction and survival. J Hepatol 1993;18:68-73.
86. Dhillon AP, Burroughs AK, Hudson M, Shah N, Rolles K, Scheuer PJ. Hepatic venular stenosis after orthotopic liver transplantation. HEPATOLOGY 1994;19:106-111.
87. Demetris AJ. Central venulitis in liver allografts: considerations of differential diagnosis. HEPATOLOGY 2001;33:1329-1330.
88. Harrison RF, Davies MH, Neuberger JM, Hubscher SG. Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? HEPATOLOGY 1994;20:356-361.
89. Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-481.
90. Gow PJ, Chapman RW. Liver transplantation for primary sclerosing cholangitis. Liver 2000;20:97-103.
91. Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. HEPATOLOGY 1999;30:1121-1127.
92. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. HEPATOLOGY 1995;22:451-457.
93. Sebagh M, Debette M, Samuel D, Emile JF, Falissard B, Cailliez V, et al. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. HEPATOLOGY 1999;30:1144-1150.
94. Turlin B, Slapak GI, Hayllar KM, Heaton N, Williams R, Portmann B. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients. Liver Transpl Surg 1995;1:285-289.
95. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995;60:1098-1103.
96. Ludwig J, Gross JB Jr, Perkins JD, Moore SB. Persistent centrilobular necroses in hepatic allografts. Hum Pathol 1990;21:656-661.
97. Te HS, Koukoulis G, Ganger DR. Autoimmune hepatitis: a histological variant associated with prominent centrilobular necrosis. Gut 1997;41:269-271.
98. Nakazawa Y, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, et al. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients. Transplantation 2000;69:1599-1608.
99. Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002;74:1290-1296.
100. Farges O, Bismuth H, Sebagh M, Reynes M. Granulomatous destruction of bile ducts after liver transplantation: primary biliary cirrhosis recurrence or hepatitis C virus infection? HEPATOLOGY 1995;21:1765-1767.